Clinical Trial Update: A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosis

View source ↗

Summary

A Novartis-sponsored clinical trial is evaluating various injectable and oral treatments for relapsing multiple sclerosis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing Multiple Sclerosis

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Relapsing Multiple Sclerosis | Status: RECRUITING